Ocean Biomedical Inc. has discovered bispecific antibodies that target Chitinase 3-like-1 (CHI3L1) and immune checkpoint inhibitors, killing glioblastoma cells and melanoma cells, and blocking the metastasis of malignant melanoma cells to the lung by over 90%.